Effydral Tablets

Pajjiż: Irlanda

Lingwa: Ingliż

Sors: HPRA (Health Products Regulatory Authority)

Ingredjent attiv:

Anhydrous citric acid; Potassium chloride; Sodium chloride ; Sodium hydrogen carbonate; Glycine; Lactose monohydrate

Disponibbli minn:

Zoetis Belgium S.A.

Kodiċi ATC:

QB05XA

INN (Isem Internazzjonali):

Anhydrous citric acid; Potassium chloride; Sodium chloride ; Sodium hydrogen carbonate; Glycine; Lactose monohydrate

Dożaġġ:

. gram/tablet

Għamla farmaċewtika:

Effervescent tablet

Tip ta 'preskrizzjoni:

LM: Licensed Merchant as defined in relevant national legislation

Grupp terapewtiku:

Cattle

Żona terapewtika:

Electrolyte solutions

Indikazzjonijiet terapewtiċi:

Electrolytes

L-istatus ta 'awtorizzazzjoni:

Authorised

Data ta 'l-awtorizzazzjoni:

2013-12-09

Karatteristiċi tal-prodott

Health Products Regulatory Authority
31 July 2017
CRN000TZ9
Page 1 of 5
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Effydral Tablets
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains :
Active substance
Sodium chloride
2.34
g
Potassium chloride
1.12
g
Sodium hydrogen carbonate 6.72
g
Anhydrous citric acid
3.84
g
Lactose monohydrate
32.44
g
Glycine
2.25
g
When one Effydral tablet is dissolved in 1 litre of water, the
resulting isotonic oral
rehydration solution has the following composition:
Constituent
(mmol/l)
Sodium
120
Potassium
15
Chloride
55
Bicarbonate + citrate 80*
Lactose
90**
Glycine
30
* Total alkali expressed as bicarbonate equivalents
** 90 mmol lactose is equivalent to 180 mmol glucoseFor a full list of
excipients see
section 6.1.
3 PHARMACEUTICAL FORM
Effervescent tablet.
Health Products Regulatory Authority
31 July 2017
CRN000TZ9
Page 2 of 5
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Calves
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Effydral solution corrects dehydration, electrolyte loss and metabolic
acidosis,
particularly when these disturbances arise as a consequence of
diarrhoea.
Effydral has been specially developed for the treatment of diarrhoea
in calves.
4.3 CONTRAINDICATIONS
If the gastro-intestinal tract is completely obstructed, great care
should be taken
when administering oral solutions.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
For oral administration only.
Always use clean water and equipment when preparing Effydral solution.
Replace
with fresh solution every 24 hours.
Follow the instructions for use exactly. Use of a too-dilute Effydral
solution will have a
reduced efficacy while use of a too-concentrated solution may result
in osmotic
diarrhoea. If a too-concentrated solution is fed, ensure that the
animal has free
access to drinking water.
Ensure that newborn animals receive adequate colostrum.
In very severe cases of dehydration additional intravenous fluid
therapy may be
requi